Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph early_phase_1
2
50%
Ph phase_2
1
25%
Ph phase_4
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (50.0%)
Phase 21 (25.0%)
Phase 41 (25.0%)

Trials by Status

completed375%
not_yet_recruiting125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_2

APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)

NCT07492134
completedearly_phase_1

Mechanisms of Probiotics and Antibiotic-Associated Diarrhea

NCT04414722
completedearly_phase_1

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics

NCT03755765
completedphase_4

Antibiotic-Associated Diarrhea and the Role of Microorganisms in the Gut

NCT04156555

Clinical Trials (4)

Showing 4 of 4 trials
NCT07492134Phase 2

APLAUD Trial (Antibiotics vs PLacebo for Acute Uncomplicated Diverticulitis)

Not Yet Recruiting
NCT04414722Early Phase 1

Mechanisms of Probiotics and Antibiotic-Associated Diarrhea

Completed
NCT03755765Early Phase 1

Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics

Completed
NCT04156555Phase 4

Antibiotic-Associated Diarrhea and the Role of Microorganisms in the Gut

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4